Forasartan is an angiotensin II receptor blocker (ARB) primarily used in the management of hypertension. By acting as a competitive antagonist at the AT1 receptor subtype, this compound inhibits the physiological… Read more
Forasartan is an angiotensin II receptor blocker (ARB) primarily used in the management of hypertension. By acting as a competitive antagonist at the AT1 receptor subtype, this compound inhibits the physiological effects of angiotensin II, such as vasoconstriction and sodium retention, thereby effectively reducing systemic vascular resistance. For pharmaceutical laboratories and researchers engaged in drug development, access to high-quality materials is essential for maintaining rigorous analytical standards. This category features Forasartan along with its related compounds, including synthesis-related impurities, potential degradation products, metabolites, and stable isotope-labelled compounds. These reference standards are critical for comprehensive impurity profiling, accurate method validation, and ongoing quality control. Utilizing these characterized compounds allows laboratories to ensure regulatory compliance, assess product stability, and confirm the safety and efficacy of pharmaceutical formulations throughout their development lifecycle.